- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/34 - Tobacco-abuse
Patent holdings for IPC class A61P 25/34
Total number of patents in this class: 406
10-year publication summary
|
11
|
12
|
36
|
26
|
26
|
21
|
23
|
26
|
17
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Fertin Pharma A/S | 277 |
18 |
| McNeil AB | 169 |
16 |
| Achieve Life Sciences, Inc. | 36 |
9 |
| Antecip Bioventures II LLC | 352 |
7 |
| Shanghai Haiyan Pharmaceutical Technology Co. Ltd | 108 |
7 |
| Yangtze River Pharmaceutical (Group) Co., Ltd. | 145 |
7 |
| Emplicure AB | 18 |
6 |
| Achieve Pharma UK Limited | 7 |
6 |
| NFL Biosciences | 6 |
6 |
| Antidote Therapeutics, Inc. | 10 |
6 |
| Eolas Therapeutics, Inc. | 13 |
5 |
| Pacific University | 21 |
5 |
| H. Lundbeck A/S | 1246 |
5 |
| Biohit Oyj | 50 |
4 |
| LTS Lohmann Therapie-Systeme AG | 692 |
4 |
| Arena Pharmaceuticals, Inc. | 361 |
3 |
| Demerx, Inc. | 76 |
3 |
| Medichem, S.A. | 81 |
3 |
| Pierre Fabre Medicament | 545 |
3 |
| Research Triangle Institute | 413 |
3 |
| Other owners | 280 |